Related Experiment Video
Updated: Aug 20, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Dynamic of Circulating DNAM-1+ Monocytes and NK Cells in Patients with STEMI Following Primary Percutaneous Coronary
Marko Kumric1, Hrvoje Urlic1, Admira Bilalic2
1Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia.
Insights
This study tracked DNAX accessory molecule-1 (DNAM-1) expressing immune cells after heart attack (STEMI). Monocyte and NK cell levels dropped post-procedure but recovered, correlating with injury extent.
Area of Science:
- Immunology
- Cardiology
- Cell Biology
Background:
- Inflammation and cardiac remodeling after myocardial infarction (MI) are critical but incompletely understood.
- DNAX accessory molecule-1 (DNAM-1), an activating receptor, is implicated in cardiac remodeling post-coronary artery occlusion.
Purpose of the Study:
- To investigate the dynamic changes of DNAM-1-expressing monocytes and NK cells in peripheral blood during the early phase after reperfusion in ST-elevation MI (STEMI) patients.
Main Methods:
- Flow cytometry analysis of peripheral blood samples from 49 STEMI patients at admission, 3 hours, and 24 hours post-primary percutaneous coronary intervention (pPCI).
- Quantification of circulating DNAM-1+ monocytes (CD16++ and CD14++) and CD56dimCD16++NK cells.
Main Results:
- Circulating DNAM-1+ monocytes and NK cells significantly decreased 3 hours post-pPCI, returning to baseline by 24 hours (p=0.003, p<0.001, p=0.002).
- This dynamic was age-dependent.
- A positive correlation was found between high-sensitivity troponin I levels and CD16++DNAM-1+ monocyte counts 3 hours post-pPCI (r=0.431, p=0.003).
Conclusions:
- The study characterized the post-reperfusion dynamics of DNAM-1-expressing leukocytes in STEMI patients.
- The number of CD16++ DNAM-1+ monocytes correlates with the extent of myocardial injury, suggesting a role in post-MI cardiac remodeling.
Abstract:
Although the role of inflammation and adverse cardiac remodeling in myocardial infarction (MI) have been extensively explored, gaps in knowledge on the complex interaction between these processes still exist. Data suggest that DNAX accessory molecule-1 (DNAM-1), an activating receptor implicated in NK cell education, may be involved in cardiac remodeling following coronary artery occlusion. In the present study, we aimed to explore the dynamic of DNAM-1+ monocytes and NK cells in peripheral blood in the early phase following reperfusion in patients with ST-elevation MI (STEMI). The study enrolled 49 patients older than 18 years of age diagnosed with STEMI, referred to primary percutaneous coronary intervention (pPCI). Blood samples were obtained at three distinct points (at admission, 3 h, and 24 h after pPCI) and analyzed using flow cytometry. The number of circulating DNAM-1+ monocytes (CD16++ and CD14++) and CD56dimCD16++NK cells was significantly reduced 3 h after pPCI and subsequently returned to initial levels 24 h after procedure (p = 0.003, p < 0.001, and p = 0.002, respectively). Notably, such dynamic was dependent on age of patients. A positive correlation between high sensitivity troponin I levels and number of CD16++DNAM-1+ monocytes in peripheral blood 3 h after pPCI was observed (r = 0.431, p = 0.003). In conclusion, in the present study we delineated the post-reperfusion dynamic of DNAM-1-expresing leukocytes. Additionally, we demonstrated that the number of CD16++ DNAM-1+ monocytes correlate with the extent of myocardial injury.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations